tesamorelin peptide vs retatrutide Stack Options: Cagrilintide, MOTS-C & GH Peptides Retatrutide & Tesamorelin Shelf Life

Usually delivered in 2-3 days

Only qualified laboratory personnel should handle this material under applicable institutional, local, and federal requirements

STAT: cAMP-PKA-signal transducers and activators of transcription

lowest tolerated dose Phase Step 2 Weeks Weeks 5-8 Cagrilintide Dose 0.5 mg/week Purpose Dose escalation Phase Step 3 Weeks Weeks 9-12 Cagrilintide Dose 1.0 mg/week Purpose GI side effects often peak here Phase Step 4 Weeks Weeks 13-16 Cagrilintide Dose 1.7 mg/week Purpose Approaching maintenance Phase Maintenance Weeks Weeks 17+ Cagrilintide Dose 2.4 mg/week Purpose Target dose used in late-stage study protocols Each step lasts 4 weeks